Evidence map›Paper›PMID 39518921›Full record

ArticleInternational journal of molecular sciences2024

A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine.

Hong He, Chelsea Dumesny, Judith A Carrall, Carolyn T Dillon, Katja I de Roo, Mal Eutick, Li Dong, Graham S Baldwin, Mehrdad Nikfarjam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hong HeDepartment of Surgery, University of Melbourne, Studley Road, Heidelberg, VIC 3084, Australia.ORCID 0000-0002-2342-8750
Chelsea DumesnyDepartment of Surgery, University of Melbourne, Studley Road, Heidelberg, VIC 3084, Australia.
Judith A CarrallSchool of Chemistry and Molecular Bioscience, University of Wollongong, Sydney, NSW 2522, Australia.ORCID 0000-0001-6294-1293
Carolyn T DillonSchool of Chemistry and Molecular Bioscience, University of Wollongong, Sydney, NSW 2522, Australia.
Katja I de RooSchool of Chemistry and Molecular Bioscience, University of Wollongong, Sydney, NSW 2522, Australia.
Mal EutickPhebra Pty. Ltd., Lane Cove West, Sydney, NSW 2066, Australia.
Li DongDepartment of Surgery, University of Melbourne, Studley Road, Heidelberg, VIC 3084, Australia.ORCID 0000-0002-4718-2097
Graham S BaldwinDepartment of Surgery, University of Melbourne, Studley Road, Heidelberg, VIC 3084, Australia.
Mehrdad NikfarjamDepartment of Surgery, University of Melbourne, Studley Road, Heidelberg, VIC 3084, Australia.

Funding

Phebra Ltd Pty GB
6 · The paper itself

Abstract

Arsenic trioxide (ATO) has been shown to inhibit pancreatic cancer (PC) cell growth

Indexed as

Cell ProliferationDeoxycytidineGemcitabinePancreatic NeoplasmsPeptidesAnimalsAntineoplastic AgentsApoptosisArsenicArsenicalsArsenic TrioxideCell Cycle CheckpointsCell Line, TumorDrug SynergismHumansMiceAntineoplastic AgentsArsenicArsenicalsArsenic TrioxideDeoxycytidineGemcitabinePeptidesarsenic trioxidegemcitabinepancreatic cancerpeptide-linked arsenic compoundPhAs-LHPtumor homing peptide

Identifiers

PMID39518921
PMCPMC11546692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.